Amgen Inc. - Laporan Laba Rugi (TTM)

Amgen Inc.
US ˙ NasdaqGS ˙ US0311621009

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Amgen Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 24,987 25,424 25,164 25,484 25,767 25,979 26,316 26,384 26,330 26,323 26,190 26,582 26,833 28,190 29,532 30,934 32,534 33,424 34,126 34,917
Change (%) 1.75 -1.02 1.27 1.11 0.82 1.30 0.26 -0.20 -0.03 -0.51 1.50 0.94 5.06 4.76 4.75 5.17 2.74 2.10 2.32
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 5,815 6,159 6,136 6,285 6,333 6,454 6,525 6,398 6,377 6,376 6,565 6,868 7,086 7,795 8,582 9,298 10,802 10,458 10,556 10,699
Change (%) 5.92 -0.37 2.43 0.76 1.91 1.10 -1.95 -0.33 -0.02 2.96 4.62 3.17 10.01 10.10 8.34 16.18 -3.18 0.94 1.35
% of Revenue 23.27 24.23 24.38 24.66 24.58 24.84 24.79 24.25 24.22 24.22 25.07 25.84 26.41 27.65 29.06 30.06 33.20 31.29 30.93 30.64
Gross Operating Profit 19,172 19,265 19,028 19,199 19,434 19,525 19,791 19,986 19,953 19,947 19,625 19,714 19,747 20,395 20,950 21,636 21,732 22,966 23,570 24,218
Change (%) 0.49 -1.23 0.90 1.22 0.47 1.36 0.99 -0.17 -0.03 -1.61 0.45 0.17 3.28 2.72 3.27 0.44 5.68 2.63 2.75
% of Revenue 76.73 75.77 75.62 75.34 75.42 75.16 75.21 75.75 75.78 75.78 74.93 74.16 73.59 72.35 70.94 69.94 66.80 68.71 69.07 69.36
SG&A 5,470 5,730 5,668 5,757 5,716 5,368 5,342 5,285 5,267 5,414 5,444 5,411 5,477 5,692 6,242 6,733 7,005 7,096 6,975 6,881
Change (%) 4.75 -1.08 1.57 -0.71 -6.09 -0.48 -1.07 -0.34 2.79 0.55 -0.61 1.22 3.93 9.66 7.87 4.04 1.30 -1.71 -1.35
% of Revenue 21.89 22.54 22.52 22.59 22.18 20.66 20.30 20.03 20.00 20.57 20.79 20.36 20.41 20.19 21.14 21.77 21.53 21.23 20.44 19.71
R&D 4,290 4,207 4,222 4,340 4,700 4,819 4,811 4,768 4,458 4,434 4,533 4,607 4,574 4,784 5,069 5,403 5,774 5,964 6,107 6,404
Change (%) -1.93 0.36 2.79 8.29 2.53 -0.17 -0.89 -6.50 -0.54 2.23 1.63 -0.72 4.59 5.96 6.59 6.87 3.29 2.40 4.86
% of Revenue 17.17 16.55 16.78 17.03 18.24 18.55 18.28 18.07 16.93 16.84 17.31 17.33 17.05 16.97 17.16 17.47 17.75 17.84 17.90 18.34
OpEx 15,599 16,096 16,001 16,221 16,749 16,828 16,678 16,983 16,109 16,225 16,607 16,667 18,234 18,532 20,191 21,240 22,660 23,748 23,861 24,179
Change (%) 3.19 -0.59 1.37 3.26 0.47 -0.89 1.83 -5.15 0.72 2.35 0.36 9.40 1.63 8.95 5.20 6.69 4.80 0.48 1.33
% of Revenue 62.43 63.31 63.59 63.65 65.00 64.78 63.38 64.37 61.18 61.64 63.41 62.70 67.95 65.74 68.37 68.66 69.65 71.05 69.92 69.25
Operating Income 9,388 9,328 9,163 9,263 9,018 9,151 9,638 9,401 10,221 10,098 9,583 9,915 8,599 9,658 9,341 9,694 9,874 9,676 10,265 10,738
Change (%) -0.64 -1.77 1.09 -2.64 1.47 5.32 -2.46 8.72 -1.20 -5.10 3.46 -13.27 12.32 -3.28 3.78 1.86 -2.01 6.09 4.61
% of Revenue 37.57 36.69 36.41 36.35 35.00 35.22 36.62 35.63 38.82 38.36 36.59 37.30 32.05 34.26 31.63 31.34 30.35 28.95 30.08 30.75
Interest Expense -1,276 -998 -977 -962 -956 -1,208 -1,207 -1,254 -1,326 -1,533 -1,781 -2,205 -2,596 -4,075 -4,356 -4,412 -4,429 -3,665 -3,564 -3,450
Change (%) -21.79 -2.10 -1.54 -0.62 26.36 -0.08 3.89 5.74 15.61 16.18 23.81 17.73 56.97 6.90 1.29 0.39 -17.25 -2.76 -3.20
% of Revenue -5.11 -3.93 -3.88 -3.77 -3.71 -4.65 -4.59 -4.75 -5.04 -5.82 -6.80 -8.30 -9.67 -14.46 -14.75 -14.26 -13.61 -10.97 -10.44 -9.88
Net Income 7,352 7,264 7,085 5,746 5,609 5,893 5,723 6,576 6,835 6,552 7,917 7,979 7,566 6,717 3,763 3,130 4,230 4,090 5,933 6,619
Change (%) -1.20 -2.46 -18.90 -2.38 5.06 -2.88 14.90 3.94 -4.14 20.83 0.78 -5.18 -11.22 -43.98 -16.82 35.14 -3.31 45.06 11.56
% of Revenue 29.42 28.57 28.16 22.55 21.77 22.68 21.75 24.92 25.96 24.89 30.23 30.02 28.20 23.83 12.74 10.12 13.00 12.24 17.39 18.96

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista